Clinical Trials

NCT07283939 | RECRUITING | NA
420 participants

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2026-02-13
Completion:
2030-05-01
Conditions
  • Ampulla of Vater Carcinoma
  • Appendix Carcinoma
  • Carcinoma of Unknown Primary With Gastrointestinal Profile
  • Colon Carcinoma
  • Esophageal Carcinoma
  • Gastric Carcinoma
  • Gastroesophageal Junction Carcinoma
  • Malignant Digestive System Neoplasm
  • Rectal Carcinoma
  • Small Intestinal Carcinoma
Interventions
  • OTHER
  • DRUG
No Results Yet
NCT07281833 | RECRUITING | PHASE3
250 participants

Phase III Study to Evaluate the Safety, Efficacy, and Impact on Quality of Life of Capivasertib Alongside Standard-of-care Endocrine Treatment in Patients With HR+/HER2- Advanced Breast Cancer and Progression on Prior Endocrine-based Treatment

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2025-11-27
Completion:
2030-03-31
Conditions
  • Breast Cancer
  • HR-positive Breast Cancer
  • Advanced Breast Cancer
  • Metastatic Breast Cancer
  • HER2-negative Breast Cancer
Interventions
  • DRUG
No Results Yet
NCT07277413 | RECRUITING | PHASE1
260 participants

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2026-03-04
Completion:
2028-04-30
Conditions
  • NSCLC Adenocarcinoma
  • Gastroesophageal Cancer (GC)
  • Gastric Adenocarcinoma
  • Adenocarcinoma of Esophagus
  • Squamous Cell Car. - Esophagus
  • Urothelial Carcinoma (UC)
  • Bladder Cancer
  • Mesothelioma
  • Pleural Mesothelioma
  • Peritoneal Mesothelioma
  • Non-Small Cell Lung Cancer NSCLC
  • Pancreatic Cancer
  • Biliary Tract Carcinoma
Interventions
  • DRUG
No Results Yet
NCT07226544 | RECRUITING | PHASE2
31 participants

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2026-10-01
Completion:
2027-09-08
Conditions
  • Localized Clear Cell Renal Cell Carcinoma
  • Resectable Clear Cell Renal Cell Carcinoma
  • Stage II Renal Cell Cancer AJCC v8
  • Stage III Renal Cell Cancer AJCC v8
  • Stage IV Renal Cell Cancer AJCC v8
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page